Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate

by Justin M. Honce, Kavita V. Nair, Kavita V. Nair, Brian D. Hoyt, Brian D. Hoyt, Rebecca A. Seale, Stefan Sillau, Eric Engebretson, Brittany Schurr, John R. Corboy, Timothy L. Vollmer, Enrique Alvarez
Published 2020-09-01

Curing Chronic Hepatitis C: A Cost Comparison of the Combination Simeprevir Plus Sofosbuvir vs. Protease-Inhibitor-Based Triple Therapy

by Jacob A. Langness, David Tabano, Amanda Wieland, Sarah Tise, Lindsay Pratt, Lauren Ayres Harrington, Sonia Lin, Vahram Ghuschcyan, Kavita V. Nair, Gregory T. Everson
Published 2017-05-01